Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial - PubMed (original) (raw)
Clinical Trial
Treatment of nonresponders to oral sumatriptan with zolmitriptan and rizatriptan: a comparative open trial
N T Mathew et al. Headache. 2000 Jun.
Abstract
In order to study the effect of zolmitriptan and rizatriptan in oral sumatriptan nonresponders (defined as lack of response in three or more of five attacks), 56 patients were studied in an open trial in a crossover fashion. Both zolmitriptan, 5 mg, and rizatriptan, 10 mg, were effective in the majority of sumatriptan nonresponders. The response to rizatriptan, 10 mg, appeared to be better than to zolmitriptan, 5 mg. Approximately 19% of sumatriptan nonresponders remained nonresponders to both zolmitriptan and rizatriptan.
Similar articles
- Effect of rizatriptan and other triptans on the nausea symptom of migraine: a post hoc analysis.
Lipton RB, Pascual J, Goadsby PJ, Massiou H, McCarroll KA, Vandormael K, Jiang K, Lines CR. Lipton RB, et al. Headache. 2001 Sep;41(8):754-63. doi: 10.1046/j.1526-4610.2001.01139.x. Headache. 2001. PMID: 11576198 - Profiles of 5-HT 1B/1D agonists in acute migraine with special reference to second generation agents.
Deleu D, Hanssens Y. Deleu D, et al. Acta Neurol Belg. 1999 Jun;99(2):85-95. Acta Neurol Belg. 1999. PMID: 10427351 Review. - Preference comparison of rizatriptan ODT 10-mg and sumatriptan 50-mg tablet in migraine.
Loder E, Brandes JL, Silberstein S, Skobieranda F, Bohidar N, Wang L, Boyle D, Kolodny A, Guerra F, Santanello N, Johnson-Pratt L; Rizatriptan Protocol 060 Study Group. Loder E, et al. Headache. 2001 Sep;41(8):745-53. doi: 10.1046/j.1526-4610.2001.01138.x. Headache. 2001. PMID: 11576197 Clinical Trial. - A comparative trial of zolmitriptan and sumatriptan for the acute oral treatment of migraine.
Gallagher RM, Dennish G, Spierings EL, Chitra R. Gallagher RM, et al. Headache. 2000 Feb;40(2):119-28. doi: 10.1046/j.1526-4610.2000.00017.x. Headache. 2000. PMID: 10759911 Clinical Trial. - Rizatriptan: a review of its efficacy in the management of migraine.
Dooley M, Faulds D. Dooley M, et al. Drugs. 1999 Oct;58(4):699-723. doi: 10.2165/00003495-199958040-00013. Drugs. 1999. PMID: 10551439 Review.
Cited by
- Evaluation of Patients with Insufficient Efficacy and/or Tolerability to Triptans for the Acute Treatment of Migraine: A Systematic Literature Review.
Leroux E, Buchanan A, Lombard L, Loo LS, Bridge D, Rousseau B, Hopwood N, Matthews BR, Reuter U. Leroux E, et al. Adv Ther. 2020 Dec;37(12):4765-4796. doi: 10.1007/s12325-020-01494-9. Epub 2020 Sep 29. Adv Ther. 2020. PMID: 32990921 Free PMC article. - Early migraine intervention with sumatriptan 100 mg in patients with a history of nonresponse to sumatriptan 50 mg: an open-label, prospective study of multiple attacks.
Landy S, McGinnis J. Landy S, et al. Curr Ther Res Clin Exp. 2004 Jul;65(4):353-9. doi: 10.1016/j.curtheres.2004.06.003. Curr Ther Res Clin Exp. 2004. PMID: 24672090 Free PMC article. - Effect of preventive (beta blocker) treatment, behavioural migraine management, or their combination on outcomes of optimised acute treatment in frequent migraine: randomised controlled trial.
Holroyd KA, Cottrell CK, O'Donnell FJ, Cordingley GE, Drew JB, Carlson BW, Himawan L. Holroyd KA, et al. BMJ. 2010 Sep 29;341:c4871. doi: 10.1136/bmj.c4871. BMJ. 2010. PMID: 20880898 Free PMC article. Clinical Trial. - Clinical and economic comparison of frovatriptan versus other oral triptans in the treatment of acute migraine in the real-world setting.
Guidotti M, Ravasio R. Guidotti M, et al. Clin Drug Investig. 2009;29(11):693-702. doi: 10.2165/11315330-000000000-00000. Clin Drug Investig. 2009. PMID: 19813772 Review. - Rizatriptan in the treatment of migraine.
Láinez MJ. Láinez MJ. Neuropsychiatr Dis Treat. 2006 Sep;2(3):247-59. doi: 10.2147/nedt.2006.2.3.247. Neuropsychiatr Dis Treat. 2006. PMID: 19412472 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical